Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
64
ARM Quote, Financials, Valuation and Earnings
Last price:
$119.71
Seasonality move
:
10.39%
Day range:
$118.05 - $123.70
52-week range:
$85.61 - $188.75
Dividend yield:
0%
P/E ratio:
159.70x
P/S ratio:
34.87x
P/B ratio:
19.93x
Volume:
3.4M
Avg. volume:
5.8M
1-year change:
-4.41%
Market cap:
$127.9B
Revenue:
$3.2B
EPS (TTM):
$0.76
Analysts' Opinion
-
Consensus RatingARM Holdings PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 13 Hold ratings, and 3 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $158.43, ARM Holdings PLC has an estimated upside of 30.54% from its current price of $121.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $73.00 representing 100% downside risk from its current price of $121.37.
Fair Value
-
According to the consensus of 33 analysts, ARM Holdings PLC has 30.54% upside to fair value with a price target of $158.43 per share.
ARM vs. S&P 500
-
Over the past 5 trading days, ARM Holdings PLC has overperformed the S&P 500 by 2.9% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ARM Holdings PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ARM Holdings PLC has grown year-over-year revenues for 6 quarters straight. In the most recent quarter ARM Holdings PLC reported revenues of $983M.
Earnings Growth
-
ARM Holdings PLC has grown year-over-year earnings for 1 quarter straight. In the most recent quarter ARM Holdings PLC reported earnings per share of $0.24.
Enterprise value:
125.3B
EV / Invested capital:
19.51x
Price / LTM sales:
34.87x
EV / EBIT:
282.74x
EV / Revenue:
33.91x
PEG ratio (5yr expected):
0.18x
EV / Free cash flow:
200.08x
Price / Operating cash flow:
205.76x
Enterprise value / EBITDA:
203.66x
Gross Profit (TTM):
$3.6B
Return On Assets:
10.2%
Net Income Margin (TTM):
21.82%
Return On Equity:
14.19%
Return On Invested Capital:
14.19%
Operating Margin:
17.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | $2.9B | $3.7B | $824M | $983M | |
| Gross Profit | -- | $2.8B | $3.6B | $788M | $955M | |
| Operating Income | -- | $46M | $443M | $140M | $175M | |
| EBITDA | -- | $210M | $615M | $182M | $222M | |
| Diluted EPS | -- | $0.08 | $0.76 | $0.08 | $0.24 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $3.6B | $4.3B | |
| Total Assets | -- | -- | -- | $7.1B | $8.5B | |
| Current Liabilities | -- | -- | -- | $866M | $874M | |
| Total Liabilities | -- | -- | -- | $2.1B | $2.1B | |
| Total Equity | -- | -- | -- | $5B | $6.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $906M | $806M | $310M | $423M | |
| Cash From Investing | -- | -$367M | -$17M | -$123M | $152M | |
| Cash From Financing | -- | -$97M | -$296M | -$48M | -$26M | |
| Free Cash Flow | -- | $762M | $626M | $259M | $360M | |
ARM
Sector
Market Cap
$127.9B
$91.6M
Price % of 52-Week High
64.3%
60%
Dividend Yield
0%
0%
Shareholder Yield
--
0.82%
1-Year Price Total Return
-4.41%
-15.91%
Beta (5-Year)
--
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$117.98
200-day SMA
Sell
Level
$142.84
Bollinger Bands (100)
Sell
Level
128.67 - 155.35
Chaikin Money Flow
Buy
Level
154.4M
20-day SMA
Sell
Level
$131.78
Relative Strength Index (RSI14)
Sell
Level
41.81
ADX Line
Sell
Level
24.47
Williams %R
Neutral
Level
-66.7633
50-day SMA
Sell
Level
$144.14
MACD (12, 26)
Sell
Level
-9.43
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
354.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (30.9922)
Buy
CA Score
(Annual)
Level (0.3825)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.6308)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arm Holdings is the intellectual property owner and developer of the ARM architecture, which is used in 99% of the world’s smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.
Stock Forecast FAQ
In the current month, ARM has received 17 Buy ratings 13 Hold ratings, and 3 Sell ratings. The ARM average analyst price target in the past 3 months is $158.43.
-
Where Will ARM Holdings PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that ARM Holdings PLC share price will rise to $158.43 per share over the next 12 months.
-
What Do Analysts Say About ARM Holdings PLC?
Analysts are divided on their view about ARM Holdings PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ARM Holdings PLC is a Sell and believe this share price will drop from its current level to $73.00.
-
What Is ARM Holdings PLC's Price Target?
The price target for ARM Holdings PLC over the next 1-year time period is forecast to be $158.43 according to 33 Wall Street analysts, 17 of them rate the stock a Buy, 3 rate the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is ARM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ARM Holdings PLC is a Buy. 17 of 33 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARM?
You can purchase shares of ARM Holdings PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ARM Holdings PLC shares.
-
What Is The ARM Holdings PLC Share Price Today?
ARM Holdings PLC was last trading at $119.71 per share. This represents the most recent stock quote for ARM Holdings PLC. Yesterday, ARM Holdings PLC closed at $121.37 per share.
-
How To Buy ARM Holdings PLC Stock Online?
In order to purchase ARM Holdings PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
